Rhopressa

Arrow flying toward bullseye

Pharma

Alcon is adding 2 more arrows to its opthalmic eye drop quiver

The buyout will let Alcon get its hands on Aerie’s marketed glaucoma and ocular hypertension meds Rhopressa and Rocklatan.

Fraiser Kansteiner Aug 23, 2022 9:24am

fda

With La Jolla's Giapreza nod, FDA hits 46 for the year

Dec 22, 2017 9:50am

green

Aerie plots hiring push to roll out $400M Rhopressa

Dec 19, 2017 11:20am